BROSHY ERAN sold TBPH
November 26, 2025 · Form 4 insider transaction
BROSHY ERAN sold 15,501 shares of Theravance Biopharma, Inc. at $20.00 per share, a transaction worth $310.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,501
Price
$20.00
Total value
$310.0K
InsiderBROSHY ERAN
RoleDirector
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateNovember 26, 2025
Filing dateDecember 1, 2025
Shares owned after44,703
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024.